Collecting Spinal Fluid from Advanced Breast Cancer Patients
Part of Cancer, Skin clinical trials.
This study collects spinal fluid samples from people with advanced (metastatic) HER2-positive or triple-negative breast cancer who have never had, and currently do not have, cancer spread to the brain. Researchers want to understand how cancer cells might reach the nervous system and develop better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Pathology-confirmed diagnosis of HER2-positive breast cancer OR triple-negative breast cancer that has spread beyond the breast
- No prior history and no current signs of cancer spread to the brain (confirmed by MRI scan)
- Age 18 or older
- Able to safely undergo a lumbar puncture (spinal tap) and brain MRI
- Kidney function within acceptable limits (measured by creatinine blood test)
- Able to understand and sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue and/or blood samples from people with breast cancer to help future research. It may be useful if you’re already having surgery or another procedure as part of your treatment plan.
This study looks at genetic material from spinal fluid to better understand breast cancer that has spread to the brain or its lining. It may help doctors find new ways to treat this type of cancer.
This study looks at using a liquid biopsy (a simple test on spinal fluid) to find cancer DNA in the fluid around the brain and spine. The goal is to see if this test can guide more targeted treatment for cancers that have spread to the central nervous system.
This study collects tissue samples and health information from people with breast cancer that has spread or come back. It aims to help researchers learn more about the disease and may lead to better treatments.
This study collects and stores tissue and fluid samples from people with a breast lump or breast cancer so researchers can study cancer biology in the future. It may help future patients by allowing better lab tests and research on why breast cancer starts, grows, and comes back.
This trial tests a new drug, NBQ72S, for people with breast cancer that has spread to the lining of the brain or spinal cord (leptomeningeal metastasis). It aims to see if the drug is safe and helpful for these patients.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.